Daniele Martinelli

Medicine & Life Sciences

1. Migraine Disorders 100%
2. erenumab 51%
3. Neurological Rehabilitation 29%
4. Amyotrophic Lateral Sclerosis 29%
5. Headache 26%
6. Transcranial Direct Current Stimulation 23%
7. Vascular Dementia 22%
8. Machine Learning 20%
9. RNS60 20%
10. lasmiditan 18%
11. Atrophy 15%
12. Parkinson Disease 15%
13. Magnetic Resonance Imaging 14%
14. incobotulinumtoxinA 14%
15. Alzheimer Disease 14%
16. Secondary Headache Disorders 14%
17. Differential Diagnosis 13%
18. Randomized Controlled Trials 13%
19. Primary Headache Disorders 12%
20. Guidelines 11%
21. Therapeutics 11%
22. Coronavirus 11%
23. Type A Botulinum Toxins 10%
24. Polyneuropathies 10%
25. Health Care Outcome Assessment 9%
26. Neurosciences 9%
27. Clinical Trials 9%
28. Myelin Sheath 9%
29. Freezing 9%
30. Gait 8%
31. Placebos 8%
32. onabotulinum toxin A 8%
33. Rehabilitation 8%
34. Glycoproteins 7%
35. Equipment and Supplies 7%
36. Theoretical Models 7%
37. Quality of Life 7%
38. Thalamus 7%
39. Comorbidity 7%
40. Meta-Analysis 6%
41. Calcitonin Gene-Related Peptide 6%
42. Nitroglycerin 6%
43. Psychology 6%
44. Brain 5%
45. Prospective Studies 5%
46. Antibodies 5%
47. Upper Extremity 5%
48. Wavelet Analysis 5%
49. Dementia 5%